Polyphenols Modulate Alzheimer's Amyloid Beta Aggregation in a Structure-Dependent Manner

被引:64
|
作者
Phan, Huong T. T. [1 ]
Samarat, Kaouthar [1 ]
Takamura, Yuzuru [1 ]
Azo-Oussou, Auriane F. [2 ]
Nakazono, Yasutaka [2 ]
Vestergaard, Mun'delanji C. [2 ]
机构
[1] Japan Adv Inst Sci & Technol, 1-1 Asahidai, Nomi City, Ishikawa 9231292, Japan
[2] Kagoshima Univ, Dept Food Sci & Biotechnol, 1-21-24 Korimoto, Kagoshima 8908580, Japan
来源
NUTRIENTS | 2019年 / 11卷 / 04期
关键词
polyphenols; flavonoids; trans-stilbenes; bioactivity; amyloid beta aggregation; modulation; ELECTROCHEMICAL OXIDATION; ALPHA-SYNUCLEIN; FIBRILS; FLAVONOIDS; MECHANISM; PATHOLOGY; CURCUMIN; PEPTIDE; DAMAGE; IRON;
D O I
10.3390/nu11040756
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Some polyphenols, which are common natural compounds in fruits, vegetables, seeds, and oils, have been considered as potent inhibitors of amyloid beta (A) aggregation, one critical pathogenic event in Alzheimer's disease (AD). However, the mechanisms by which polyphenols affect aggregation are not fully understood. In this study, we aimed to investigate the effect of two classes of polyphenols (flavonoids and stilbenes) on the self-assembly of A_42, in particular, how this relates to structure. We found that the flavonoids gallocatechin gallate (GCG) and theaflavin (TF) could completely inhibit A aggregation, while two stilbenes, resveratrol and its glucoside derivative piceid, could also suppress A aggregation, but to a much lesser extent. Intriguingly, resveratrol accelerated the formation of A fibrils before its decreasing effect on fibrillation was detected. Atomic force microscopy (AFM) images showed a huge mass of long and thin A fibrils formed in the presence of resveratrol. Although the morphology was the same in the presence of piceid, the fibrils were sparse in the presence of picead. In the presence of flavonoids, A morphology was unchanged from prior to incubation (0 h), in agreement with amyloid beta kinetics analysis using thioflavin-T fluorescence assay. The electrochemical data showed a higher ability of GCG and TF to interact with A than resveratrol and piceid, which could be attributed to the presence of more aromatic rings and hydroxyl groups. In addition, the two flavonoids exhibited a similar propensity for A aggregation, despite having some differences in their structure. However, in the case of stilbenes, the addition of a glucoside at C-7 slightly decreased anti-A aggregation property compared to resveratrol. These findings contribute to a better understanding of the essential structural features of polyphenols required for inhibiting A aggregation, and the possible mechanisms for modulating aggregation.
引用
收藏
页数:15
相关论文
共 50 条
  • [21] Rationally Designed Peptoids Modulate Aggregation of Amyloid-Beta 40
    Turner, J. Phillip
    Lutz-Rechtin, Tammy
    Moore, Kelly A.
    Rogers, Lauren
    Bhave, Omkar
    Moss, Melissa A.
    Servoss, Shannon L.
    ACS CHEMICAL NEUROSCIENCE, 2014, 5 (07): : 552 - 558
  • [22] Multifocal Cerebral Microinfarcts Modulate Early Alzheimer's Disease Pathology in a Sex-Dependent Manner
    Lecordier, Sarah
    Pons, Vincent
    Rivest, Serge
    ElAli, Ayman
    FRONTIERS IN IMMUNOLOGY, 2022, 12
  • [23] Pomegranate polyphenols inhibit the formation of advanced glycation endproducts and aggregation of beta amyloid
    Ma, Hang
    Liu, Weixi
    Niesen, Daniel
    Dain, Joel
    Seeram, Navindra
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2015, 250
  • [24] Screening for Novel Inhibitors of Amyloid Beta Aggregation and Toxicity as Potential Drugs for Alzheimer's Disease
    Sharari, Sanaa
    Vaikath, Nishant N.
    Tsakou, Magdalini
    Ghanem, Simona S.
    Vekrellis, Kostas
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (14)
  • [25] Synthesis and evaluation of heterocyclic biaryls as aggregation inhibitors for Alzheimer's amyloid-beta peptide
    Hernandez, Benjamin
    Murray, Mouskudah
    Crenshaw, Brandy
    Vinson, Augustine
    Hurtt, Matthew
    Lammi, Robin
    Hanna, James
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 255
  • [26] Amyloid-beta aggregation implicates multiple pathways in Alzheimer's disease: Understanding the mechanisms
    Iliyasu, Musa O.
    Musa, Sunday A.
    Oladele, Sunday B.
    Iliya, Abdullahi I.
    FRONTIERS IN NEUROSCIENCE, 2023, 17
  • [27] Beta Amyloid Aggregation Inhibitors: Small Molecules as Candidate Drugs for Therapy of Alzheimer's Disease
    Re, F.
    Airoldi, C.
    Zona, C.
    Masserini, M.
    La Ferla, B.
    Quattrocchi, N.
    Nicotra, F.
    CURRENT MEDICINAL CHEMISTRY, 2010, 17 (27) : 2990 - 3006
  • [28] α-Sheet secondary structure in amyloid β-peptide drives aggregation and toxicity in Alzheimer's disease
    Shea, Dylan
    Hsu, Cheng-Chieh
    Bi, Timothy M.
    Paranjapye, Natasha
    Childers, Matthew Carter
    Cochran, Joshua
    Tomberlin, Colson P.
    Wang, Libo
    Paris, Daniel
    Zonderman, Jeffrey
    Varani, Gabriele
    Link, Christopher D.
    Mullan, Mike
    Daggett, Valerie
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2019, 116 (18) : 8895 - 8900
  • [29] Assembly and structure of Alzheimer's A-beta amyloid-like fibrils
    Goldsbury, C
    Aebi, U
    Frey, P
    MOLECULAR BIOLOGY OF THE CELL, 2002, 13 : 139A - 139A
  • [30] Molecular mechanism of Alzheimer's β-amyloid peptide aggregation
    Li, Yanyan
    Mao, Xiwen
    Liu, Keyu
    Niu, Zheng
    CHINESE SCIENCE BULLETIN-CHINESE, 2024, 69 (07): : 903 - 911